Targets Q4 2026 for the completion of AI data center conversions at Wenatchee, Washington, and the first phase of Knoxville, ...
Data spans seven presentations across both solid tumors and hematologic malignancies, providing updates on the potential benefit these therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results